Figure 3From: Long term physiologic modification using rAAV in utero gene-therapyExpression of GFP in lungs at one year of age following in utero rAAVcntf-gfp gene therapy. Rats were treated at 16 days gestation with rAAVcntf-gfp at high (2.5 × 109), medium (2.5 × 108) and low (2.5 × 107) pfu/ml doses. Lungs were harvested at 1 year of age and GFP-specific protein identified by western blotBack to article page